Suchergebnisse - "Tai, Lin"

PubPharm (7)

1

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma

enthalten in: International journal of molecular sciences | 2021

von Chou, M. | Chuang, H. | Lin, Y. | +6

2

Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection

enthalten in: Immunity | 2020

von Doerflinger, M. | Deng, Y. | Whitney, P. | +25

CommentIn: Immunity. 2020 Sep 15;53(3):471-473. - PMID 32937145

3

Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM

enthalten in: Cell death and differentiation | 2016

von Rohrbeck, L. | Gong, J. | Lee, E. | +8

4

Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

enthalten in: Head & neck | 2016

von Li, S. | Lin, W. | Huang, T. | +10

5

Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer

enthalten in: Molecular cancer | 2015

von Chen, C. | Chang, A. | Li, S. | +8

6

A novel antitubulin agent, DPQZ, induces cell apoptosis in human oral cancer cells through Ras/Raf inhibition and MAP kinases activation

enthalten in: Archives of toxicology | 2013

von Hour, M. | Lee, K. | Wu, Y. | +4

7

Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis

enthalten in: PloS one | 2013

von Hwang, C. | Shiu, L. | Su, L. | +10

RetractionIn: PLoS One. 2020 Jan 9;15(1):e0227931. - PMID 31917820

1
[1]